Install
조선비즈는 국내 최고의 온라인 경제 전문 미디어로, 정책, 금융, 부동산, 기업, 글로벌 경제 등 정보를 제공합니다.
- 9,737articles · 30d
- 59+ min agolatest article
- Aug 14, 2026earliest in window
- 90%with images
- 99avg words
- south korea 3,377
- business information 3,288
- politics 3,022
- society 2,817
- entertainment 2,730
- hallyu 2,689
- korea news 2,658
- celebrity 2,643
- korean entertainment 2,635
- sports 2,571
- the asia business daily 2,503
- newspaper 2,449
- korea 2,409
- economic 2,357
- k-drama 2,273
- issue 2,268
- k-variety 2,241
- kst 2,040
- business 1,730
- k-pop 1,542
- Entertainment 3,296
- Arts & Entertainment 2,870
- Sports & Fitness 2,413
- Economy, Business & Finance 2,299
- Sports 2,272
- Sport 2,123
- Human Interest 1,998
- Arts, Culture, Entertainment & Media 1,838
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
KOSME launches healing camp to help South Korea’s re-entrepreneurs restart
9+ hour, 57+ min ago (12+ words) CHOSUNBIZ Chosunbiz...
GC Biopharma wins phase 2 nod for COVID-19 mRNA shot, targets Korea production by 2028
2+ day, 11+ hour ago (244+ words) Phase 2 to test dosing and immune response in adults as company eyes homegrown mRNA capacity by 2028 GCBiopharma will enter phase 2 of a coronavirus messenger ribonucleic acid (mRNA) vaccine candidate it is developing in-house. It plans to begin dosing the first…...
Pharma giants race to invest in immune therapies as market growth accelerates
2+ day, 14+ hour ago (708+ words) Big drugmakers double down on next‑gen immunology, from long-lasting antibodies to AI-guided discovery Global big pharma (large drugmakers) are opening their wallets one after another to secure new drugs for immune diseases. U.S. drugmaker AbbVie acquired an immunology biotech…...
Dyson enters South Korea’s oral care market with 749,000‑won AI toothbrush
3+ day, 8+ hour ago (15+ words) CHOSUNBIZ Chosunbiz...
FDA halts new enrollment in SK Biopharm epilepsy trials, seeks toxin data
3+ day, 3+ hour ago (14+ words) CHOSUNBIZ Chosunbiz...
China leads cancer research surge as South Korea strengthens but seeks edge
3+ day, 3+ hour ago (14+ words) CHOSUNBIZ Chosunbiz...
Voronoi withdraws Canada trial bid for NSCLC drug, plans swift resubmission
3+ day, 12+ hour ago (13+ words) CHOSUNBIZ biz.chosun.com...
Korea AbbVie, Boehringer Ingelheim win health ministry honors for bio R&D
3+ day, 9+ hour ago (217+ words) Korea honors AbbVie, Boehringer Ingelheim for bio research collaboration - CHOSUNBIZ Chosunbiz Korea AbbVie, Boehringer Ingelheim win health ministry honors for bio R&D Korea AbbVie and Korea Boehringer Ingelheim received a commendation from the Minister of the Ministry of Health…...
Kim Chang-ok quits psychiatric meds after finding healing in lacquer painting
3+ day, 22+ hour ago (13+ words) CHOSUNBIZ Chosunbiz...
South Korea freezes 2027 health premiums at 7.19% as Kang urges steady hikes
5+ day, 5+ hour ago (15+ words) CHOSUNBIZ Chosunbiz...